Lundin searches for more oil in North Sea fields

Feb. 7, 2014
Lundin Oil will drill an appraisal well during the current quarter on the southeastern part of the Edvard Grieg reservoir in the central Norwegian North Sea.

Offshore staff

STOCKHOLM, Sweden – Lundin Oil will drill an appraisal well during the current quarter on the southeastern part of the Edvard Grieg reservoir in the central Norwegian North Sea.

It hopes to prove more reserves and optimize the location of wells for the ongoingEdvard Grieg development.

In the same area, the company is looking to drill a second appraisal well on itsLuno II discovery in license PL359 (Luno II North) and an exploration well on the 23 MMboe Fignon Miocene prospect.

Lundin’s Barents Sea plans this year include an appraisal well on last year’sGohta discovery and an exploration well on the Alta prospect on PL609.

In the northern Norwegian North Sea, Lundin is lining up wells on the Storm prospect in PL555 and on Vollgrav in PL631, between the Statfjord and Gullfaks fields.

Farther north, the company plans exploration drilling on the Lindarormen structure in PL584 in the Norwegian Sea (south of the Åsgard field and southwest of the Draugen field); and in the Barents Sea, an appraisal well on last year’s Gohta discovery and an exploration well on the Alta prospect in PL609.

At the Marathon-operated Alvheim development in theNorth Sea, Lundin says three infill wells will be drilled during 2014-2015. However, drilling of the North Kameleon exploration prospect north of Alvheim will probably be deferred until 2015 due to delays in the semisubmersible Transocean Winner’s schedule.

For the same reason, first oil from theBøyla field has been revised to 1Q 2015, with Transocean Winner starting work on development drilling later this year. Two production wells and one water injection well will be tied back 28 km (17.4 mi) to the Alvheim FPSO via subsea facilities. Fabrication of the subsea structures is under way.

Lundin expects the BG-operatedGaupe field, which has performed below expectations, to cease production later this year.

02/07/2014